TRAVERE THERAPEUTICS, INC. Increase (Decrease) in Accrued Liabilities
TRAVERE THERAPEUTICS, INC. (TVTX) reported Increase (Decrease) in Accrued Liabilities of $2.47 million for the 22-month period ending 2012-12-31, per its 10-K/A filed 2013-09-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2013-09-16
- TRAVERE THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2012 was $2.30M.
| Period end | Increase (Decrease) in Accrued Liabilities 10 month | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 22 month |
|---|---|---|---|
| 2012-12-31 | $2.30M 10-K/A · filed 2013-09-16 | $2.47M 10-K/A · filed 2013-09-16 | |
| 2011-12-31 | $169.72K 10-K/A · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |